• Bamboozled! Trump Cancels Pharma Negotiations After Meeting with Lobbyists

    --Donald Trump reverses his drug platform after meeting with pharmaceutical lobbyists and executives, now wanting to cut taxes and regulations on big pharma and coming out against the "price-fixing" of Medicare as a way to keep prices low http://www.vox.com/policy-and-politics/2017/1/31/14453740/trump-medicare-prescription-drugs --On the Bonus Show: David's apartment problem, internal drama among progressive media, Fox News takes down its tweet about the Quebec City mosque shooting and much more... Support TDPS by clicking (bookmark it too!) this link before shopping on Amazon: http://www.amazon.com/?tag=thedavpaksho-20 Website: https://www.davidpakman.com Become a Member: https://www.davidpakman.com/membership David's Instagram: http://www.instagram.com/david.pakman Discuss This on Red...

    published: 02 Feb 2017
  • Big Pharma Spends More Money Lobbying Washington Than Any Other Industry

    Big Pharma spent $2.6 billion lobbying Congress between 1998 and 2012. They spent more on lobbying than the next two biggest spending industries -- defense and oil -- combined. As a result, according to the Patented Medicine Prices Review Board, by 2011 Americans were paying 100% more than Canadian for the same patented drugs.

    published: 02 Apr 2013
  • Big Pharma & An Army of Lobbyists Just Sidestepped the FDA

    The 21st century cures act sounds very nice, the same way that the patriot act, or the affordable health care act sounded. The 21st century cures act is supposed to accelerate the pace of cures in America, by streamlining the drug and device development process. Find out how big pharma just landed a big victory that may give a whole new meaning to the phrase ‘FDA Approved’. Show Notes http://bit.ly/2hwWfAz Join the Newsbud Community http://bit.ly/2gbO5ii Visit our website http://bit.ly/2gl9jbd Follow Newsbud on Twitter http://bit.ly/29d5XFD

    published: 14 Dec 2016
  • A message to the pharmaceutical lobbying group PhRMA

    Look in the mirror, assholes. http://www.pharmaskeletons.com

    published: 23 Jan 2017
  • Big Pharma Spent Nearly $1 Billion to Lobby US

    Drug makers spent more than $880 million between 2006 and 2015 to fight gov't restrictions on lucrative opiate drugs. http://multimedia.telesurtv.net/v/big-pharma-spent-nearly-1-billion-to-lobby-us/

    published: 22 Sep 2016
  • THE DEVIL MAKING BACK ROOM DRUG DEALS WITH PHARMACEUTICAL LOBBYIST

    published: 11 Aug 2009
  • Big Pharma Spends $900 Million To Stop State Sanctioned Drug Limits

    America’s opioid epidemic has been rapidly increased to crisis levels over the course of the last decade. However pharmaceutical companies like Purdue, which makes Oxycontin, and Pfizer, the second-largest drug company in the world have employed over 1,300 lobbyists and spent over $880 million inthe last 9 years to prevent states from enacting laws that would limit access to painkillers. A study published in 2013 found that four in five new heroin users got there by misusing opioid painkillers. However this money and lobbyists have been able to add to our growing probem with influence on our officials. http://fusion.net/story/348435/big-pharma-900-million-stop-limiting-access-to-opioids/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com

    published: 18 Sep 2016
  • Donald Trump Announces Plan To Hammer Big Pharma Monopoly Profits By Requiring Competitive Bidding

    Donald Trump Announces Plan To Hammer Big Pharma Monopoly Profits, By Requiring Competitive Bidding Check The Source Here:https://goo.gl/lj2YAH Be a Proud Patriot, Wear Your America T-Shrits: http://goo.gl/XgtvW8 Support Us, Donate For Our Cause Here: https://goo.gl/IIMAA5 , GOD Bless America During his first press conference as president-elect, Donald Trump unveiled how he plans to remove himself from his family’s business dealings to avoid any appearance of a conflict of interest while president. He also railed against the pharmaceutical industry, which he boldly described as “getting away with murder,” as he called for “new bidding procedures” to lower drug costs and presumably end the Big Pharma monopoly that has been strangling American healthcare for decades. Following throug...

    published: 25 Apr 2017
  • 60 Minutes Expose How The Lobbies Rule America

    published: 28 Oct 2015
  • How Lobbyists Secretly Run Washington: The Rich, Money & Influencing Congress, Government (1993)

    Lobbying in the United States describes paid activity in which special interests hire well-connected professional advocates, often lawyers, to argue for specific legislation in decision-making bodies such as the United States Congress. About the book: https://www.amazon.com/gp/product/0812923146/ref=as_li_tl?ie=UTF8&camp=1789&creative=9325&creativeASIN=0812923146&linkCode=as2&tag=tra0c7-20&linkId=499e98e3351ef9914747174226366cf8 It is a highly controversial phenomenon, often seen in a negative light by journalists and the American public, and frequently misunderstood. While lobbying is subject to extensive and often complex rules which, if not followed, can lead to penalties including jail, the activity of lobbying has been interpreted by court rulings as free speech and protected by the ...

    published: 22 Mar 2014
  • At Eli Lilly Headquarters: Marketing Big Pharma Profits at Risk to the Public

    We visit the headquarters of Eli Lilly in downtown Indianapolis where the power of Big Pharma has carved out Indiana's political landscape, supplied its lobbyists and operatives, and created an empire of profits by (reportedly) treating the symptoms, hiding the risk and harm, and insisting on the safety of products – like Thimerosal and Prozac – without sufficient testing, and even less regard for the lives affected. Read more at Truthstream: http://truthstreammedia.com/2015/08/14/visiting-eli-lilly-headquarters-marketing-big-pharma-profits-at-the-expense-of-public-safety/ With the shameful record of having only one sham of a study on the safety of Thimerosal back in the 1920s, Eli Lilly has had the gall to insist upon the safety of their products, even as lobbyists in Washington moved t...

    published: 14 Aug 2015
  • How Big Pharma Played a Double Game on Obamacare (w/ Eli Clifton)

    Eli Clifton, reporting fellow with The Investigative Fund at The Nation Institute, joins us to explain how Pharma played a double game on the ACA, how the Obama Administration cut deals with Pharma and Pharma funded ALEC in fighting health reform on the state level and the skill and personality of Billy Tauzin Pharma's former top lobbyist... This clip from the Majority Report, live M-F at 12 noon EST and via daily podcast at http://Majority.FM Subscribe to us on YouTube: http://youtube.com/user/SamSeder

    published: 17 Apr 2014
  • Grover Norquist Faces Questions About Big Pharma Cash And His Lobbying Past

    Grover Norquist Faces Questions About Big Pharma Cash And His Lobbying Past

    published: 22 Jun 2012
  • Draining the Pharma swamp: Donald Trump announces plan to hammer Big Pharma’s monopoly profits

    President-elect Donald Trump announced a plan to shatter the monopolistic pricing of Big Pharma that has been draining literally trillions of dollars from the government for the past two decades. “Pharma has a lot of lobbyists and a lot of power,” said Trump. “There’s very little bidding on drugs. We’re the largest drug buyer in the world, and we’re going to start bidding. We’re going to start saving billions of dollars on drugs.” Read the full story here: http://www.naturalnews.com/2017-01-11-donald-trump-announces-plan-to-attack-big-pharma-monopoly-profits-by-requiring-competitive-bidding-government-drug-purchases.html

    published: 12 Jan 2017
  • THE SWAMP: Big Pharma Spent $468,108 Per Member Of Congress

    Read More At: http://www.motherjones.com/politics/2016/10/drug-industry-pharmaceutical-lobbyists-medicare-part-d-prices/ Support The Show On Patreon: https://www.patreon.com/seculartalk Here's Our Amazon Link: https://www.amazon.com/?tag=seculacom-20 Follow Kyle on Twitter: http://www.twitter.com/kylekulinski Like the show on Facebook: http://www.facebook.com/SecularTalk Clip from The Kyle Kulinski Show, which airs live on Blog Talk Radio and Secular Talk Radio Monday - Friday 11:00 AM - 12:30 PM Eastern time zone. Listen to the Live Show or On Demand archive at: http://www.blogtalkradio.com/kylekulinski Check out our website - and become a member - at: http://www.SecularTalkRadio.com

    published: 07 Jul 2017
  • Turn the spotlight on EU lobbying!

    Sign our petition and call for an effective mandatory EU lobby register: www.change.org/eu-lobbying Secretive lobbying undermines democracy and citizens’ trust in governments and the EU institutions. Transparency International’s research shows that hidden and undue influence by lobbyists continues to shape laws across Europe. We have seen pharma lobbying keeping dangerous medicines on the market. We have seen banks writing the laws and regulations that are supposed to control them. And we have seen restrictions for the tobacco and alcohol industries pushed back time and again. Many fear that the Transatlantic Free Trade agreement (TTIP) is shaped by big-business lobbying, but without transparency we don’t know if politicians are making decisions in the best interest of the public. This is...

    published: 21 Mar 2016
Bamboozled! Trump Cancels Pharma Negotiations After Meeting with Lobbyists

Bamboozled! Trump Cancels Pharma Negotiations After Meeting with Lobbyists

  • Order:
  • Duration: 6:09
  • Updated: 02 Feb 2017
  • views: 55235
videos
--Donald Trump reverses his drug platform after meeting with pharmaceutical lobbyists and executives, now wanting to cut taxes and regulations on big pharma and coming out against the "price-fixing" of Medicare as a way to keep prices low http://www.vox.com/policy-and-politics/2017/1/31/14453740/trump-medicare-prescription-drugs --On the Bonus Show: David's apartment problem, internal drama among progressive media, Fox News takes down its tweet about the Quebec City mosque shooting and much more... Support TDPS by clicking (bookmark it too!) this link before shopping on Amazon: http://www.amazon.com/?tag=thedavpaksho-20 Website: https://www.davidpakman.com Become a Member: https://www.davidpakman.com/membership David's Instagram: http://www.instagram.com/david.pakman Discuss This on Reddit: http://www.reddit.com/r/thedavidpakmanshow/ Support Our Sponsors: http://www.influencerbridge.com/davidpakman Facebook: http://www.facebook.com/davidpakmanshow TDPS Twitter: http://www.twitter.com/davidpakmanshow David's Twitter: http://www.twitter.com/dpakman TDPS Gear: http://www.davidpakman.com/gear 24/7 Voicemail Line: (219)-2DAVIDP Subscribe to The David Pakman Show for more: http://www.youtube.com/subscription_center?add_user=midweekpolitics Timely news is important! We upload new clips every day, 6-8 stories! Make sure to subscribe! Broadcast on February 1, 2017
https://wn.com/Bamboozled_Trump_Cancels_Pharma_Negotiations_After_Meeting_With_Lobbyists
Big Pharma Spends More Money Lobbying Washington Than Any Other Industry

Big Pharma Spends More Money Lobbying Washington Than Any Other Industry

  • Order:
  • Duration: 5:57
  • Updated: 02 Apr 2013
  • views: 859
videos
Big Pharma spent $2.6 billion lobbying Congress between 1998 and 2012. They spent more on lobbying than the next two biggest spending industries -- defense and oil -- combined. As a result, according to the Patented Medicine Prices Review Board, by 2011 Americans were paying 100% more than Canadian for the same patented drugs.
https://wn.com/Big_Pharma_Spends_More_Money_Lobbying_Washington_Than_Any_Other_Industry
Big Pharma & An Army of Lobbyists Just Sidestepped the FDA

Big Pharma & An Army of Lobbyists Just Sidestepped the FDA

  • Order:
  • Duration: 10:18
  • Updated: 14 Dec 2016
  • views: 5238
videos
The 21st century cures act sounds very nice, the same way that the patriot act, or the affordable health care act sounded. The 21st century cures act is supposed to accelerate the pace of cures in America, by streamlining the drug and device development process. Find out how big pharma just landed a big victory that may give a whole new meaning to the phrase ‘FDA Approved’. Show Notes http://bit.ly/2hwWfAz Join the Newsbud Community http://bit.ly/2gbO5ii Visit our website http://bit.ly/2gl9jbd Follow Newsbud on Twitter http://bit.ly/29d5XFD
https://wn.com/Big_Pharma_An_Army_Of_Lobbyists_Just_Sidestepped_The_Fda
A message to the pharmaceutical lobbying group PhRMA

A message to the pharmaceutical lobbying group PhRMA

  • Order:
  • Duration: 10:34
  • Updated: 23 Jan 2017
  • views: 47147
videos
Look in the mirror, assholes. http://www.pharmaskeletons.com
https://wn.com/A_Message_To_The_Pharmaceutical_Lobbying_Group_Phrma
Big Pharma Spent Nearly $1 Billion to Lobby US

Big Pharma Spent Nearly $1 Billion to Lobby US

  • Order:
  • Duration: 1:06
  • Updated: 22 Sep 2016
  • views: 225
videos
Drug makers spent more than $880 million between 2006 and 2015 to fight gov't restrictions on lucrative opiate drugs. http://multimedia.telesurtv.net/v/big-pharma-spent-nearly-1-billion-to-lobby-us/
https://wn.com/Big_Pharma_Spent_Nearly_1_Billion_To_Lobby_US
THE DEVIL MAKING BACK ROOM DRUG DEALS WITH PHARMACEUTICAL LOBBYIST

THE DEVIL MAKING BACK ROOM DRUG DEALS WITH PHARMACEUTICAL LOBBYIST

  • Order:
  • Duration: 5:40
  • Updated: 11 Aug 2009
  • views: 240
videos
https://wn.com/The_Devil_Making_Back_Room_Drug_Deals_With_Pharmaceutical_Lobbyist
Big Pharma Spends $900 Million To Stop State Sanctioned Drug Limits

Big Pharma Spends $900 Million To Stop State Sanctioned Drug Limits

  • Order:
  • Duration: 0:49
  • Updated: 18 Sep 2016
  • views: 200
videos
America’s opioid epidemic has been rapidly increased to crisis levels over the course of the last decade. However pharmaceutical companies like Purdue, which makes Oxycontin, and Pfizer, the second-largest drug company in the world have employed over 1,300 lobbyists and spent over $880 million inthe last 9 years to prevent states from enacting laws that would limit access to painkillers. A study published in 2013 found that four in five new heroin users got there by misusing opioid painkillers. However this money and lobbyists have been able to add to our growing probem with influence on our officials. http://fusion.net/story/348435/big-pharma-900-million-stop-limiting-access-to-opioids/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
https://wn.com/Big_Pharma_Spends_900_Million_To_Stop_State_Sanctioned_Drug_Limits
Donald Trump Announces Plan To Hammer Big Pharma Monopoly Profits By Requiring Competitive Bidding

Donald Trump Announces Plan To Hammer Big Pharma Monopoly Profits By Requiring Competitive Bidding

  • Order:
  • Duration: 15:48
  • Updated: 25 Apr 2017
  • views: 805
videos
Donald Trump Announces Plan To Hammer Big Pharma Monopoly Profits, By Requiring Competitive Bidding Check The Source Here:https://goo.gl/lj2YAH Be a Proud Patriot, Wear Your America T-Shrits: http://goo.gl/XgtvW8 Support Us, Donate For Our Cause Here: https://goo.gl/IIMAA5 , GOD Bless America During his first press conference as president-elect, Donald Trump unveiled how he plans to remove himself from his family’s business dealings to avoid any appearance of a conflict of interest while president. He also railed against the pharmaceutical industry, which he boldly described as “getting away with murder,” as he called for “new bidding procedures” to lower drug costs and presumably end the Big Pharma monopoly that has been strangling American healthcare for decades. Following through on one of the many pro-business promises he made all along the campaign trail, Trump reiterated the need to rethink the way our country buys and sells drugs to help lower costs in the public interest. The United States is currently the largest buyer of pharmaceutical drugs in the world, and yet prices are completely out of control. Trump would like to see this change by using simple competitive market forces, a position that appeals to a strong public sentiment that Big Pharma has been getting away with far too much for far too long. “Pharma has a lot of lobbyists and a lot of power,” the president-elect proclaimed before an eager press pool, “and there’s very little bidding. We’re the largest buyer of drugs in the world and yet we don’t bid properly.” President-elect Trump’s statements come amidst the drug industry’s major annual investor conference, which is currently taking place in San Francisco. Though no specific policy proposals were presented by Trump, as to how drug pricing will change, the writing seems to be on the wall for many key players within the drug industry, which felt a major hit in the stock market following the announcement. “Our drug industry has been disastrous; [drug companies are] leaving left and right,” Trump added. “They supply our drugs but they don’t make them here, to a large extent.” Trump plan for pharmaceuticals should have bipartisan appeal; who doesn’t want more competition and lower prices? While these words by Trump might come as a warning shot for the drug industry, they are music to the ears of the American public. Tackling the Big Pharma monopoly has been a key priority for voters on both sides of the aisle for many years, explaining why former presidential candidates Hillary Clinton and Bernie Sanders also took aim at drug industry price-gouging and other anti-consumer tactics while on the campaign trail. Trump’s call for a policy of more competitive bidding to encourage lower drug prices is a message that one would expect would have drawn broader bipartisan support from both Republicans and Democrats than it has. But aggressive campaign “fake news” campaigns against the incoming Trump administration by many within the mainstream media have created an environment of continued hostility. While the president-elect tried repeatedly to outline the many ways in which he plans to level the playing field, foster transparency and serve the interests of the country, many in the press pool could only find fault with every word coming out of his mouth. At one point, CNN reporter Jim Acosta had to be told to keep quiet and stop “being rude,” after he interrupted questions from another reporter with ones of his own. “Your organization is terrible,” Trump retorted to Acosta’s continued interruptions and demands that his question be answered. “Don’t be rude. No, I’m not going to give you a question. You are fake news,” he added. Later in the day, Trump “tweeted” about the fake news phenomenon that seems to be specifically targeting Trump with attacks in a way that no other president-elect in history has faced. Trump denounced the situation in all-caps as “A TOTAL POLITICAL WITCH HUNT!”
https://wn.com/Donald_Trump_Announces_Plan_To_Hammer_Big_Pharma_Monopoly_Profits_By_Requiring_Competitive_Bidding
60 Minutes Expose  How The Lobbies Rule America

60 Minutes Expose How The Lobbies Rule America

  • Order:
  • Duration: 9:52
  • Updated: 28 Oct 2015
  • views: 3582
videos
https://wn.com/60_Minutes_Expose_How_The_Lobbies_Rule_America
How Lobbyists Secretly Run Washington: The Rich, Money & Influencing Congress, Government (1993)

How Lobbyists Secretly Run Washington: The Rich, Money & Influencing Congress, Government (1993)

  • Order:
  • Duration: 57:31
  • Updated: 22 Mar 2014
  • views: 14829
videos
Lobbying in the United States describes paid activity in which special interests hire well-connected professional advocates, often lawyers, to argue for specific legislation in decision-making bodies such as the United States Congress. About the book: https://www.amazon.com/gp/product/0812923146/ref=as_li_tl?ie=UTF8&camp=1789&creative=9325&creativeASIN=0812923146&linkCode=as2&tag=tra0c7-20&linkId=499e98e3351ef9914747174226366cf8 It is a highly controversial phenomenon, often seen in a negative light by journalists and the American public, and frequently misunderstood. While lobbying is subject to extensive and often complex rules which, if not followed, can lead to penalties including jail, the activity of lobbying has been interpreted by court rulings as free speech and protected by the US Constitution. Since the 1970s, lobbying activity has grown immensely in terms of the numbers of lobbyists and the size of lobbying budgets, and has become the focus of much criticism of American governance. Since lobbying rules require extensive disclosure, there is a wealth of data in the public sphere about which entities lobby, how, at whom, and for how much. The current pattern suggests much lobbying is done by corporations, although a wide variety of coalitions representing diverse groups is possible. Lobbying happens at every level of government, including federal, state, county, municipal, and even local governments. In Washington, DC, lobbying usually targets congresspersons, although there have been efforts to influence executive agency officials as well as US Supreme Court appointments. It has been the subject of academic inquiry in various fields, including economics, law, and public policy. While lobbyists number of 12,000 people in Washington, DC, those with real clout number in the dozens, and a small group of firms handles much of lobbying in terms of expenditures. As an activity, lobbying takes time to learn, requires skill and sensitivity, depends on deft persuasion, and has much in common with generally non-political activities such as management consulting and public relations. http://en.wikipedia.org/wiki/Lobbyists Numerous reports chronicle the revolving door phenomenon.[42] A 2011 estimate suggested that nearly 5,400 former congressional staffers had become federal lobbyists over a ten-year period, and 400 lawmakers made a similar jump.[46] It is a "symbiotic relationship" in the sense that lobbying firms can exploit the "experience and connections gleaned from working inside the legislative process", and lawmakers find a "ready pool of experienced talent."[46] There is movement in the other direction as well: one report found that 605 former lobbyists had taken jobs working for lawmakers over a ten-year period.[46] A study by the London School of Economics found 1,113 lobbyists who had formerly worked in lawmakers' offices.[46] The lobbying option is a way for staffers and lawmakers to "cash in on their experience", according to one view.[28] Before the 1980s, staffers and aides worked many years for congresspersons, sometimes decades, and tended to stay in their jobs; now, with the lure of higher-paying lobbying jobs, many would quit their posts after a few years at most to "go downtown."[28] And it is not just staffers, but lawmakers as well, including high-profile ones such as congressperson Richard Gephardt. He represented a "working-class" district in Missouri for many years but after leaving Congress, he became a lobbyist.[80] In 2007, he began his own lobbying firm called "Gephardt Government Affairs Group" and in 2010 it was earning close to $7 million in revenues with clients including Goldman Sachs, Boeing, Visa Inc., Ameren Corporation, and Waste Management Inc..[80] Senators Robert Bennett and Byron Dorgan became lobbyists too.[81] Mississippi governor Haley Barbour became a lobbyist.[82] In 2010, former representative Billy Tauzin earned $11 million running the drug industry's lobbying organization. called the Pharmaceutical Research and Manufacturers of America.[80] Many former representatives earned over $1 million in one year, including James Greenwood and Daniel Glickman. When getting access is difficult, there are ways to wear down the walls surrounding a legislator. Jack Abramoff explained: Access is vital in lobbying. If you can't get in your door, you can't make your case. Here we had a hostile senator, whose staff was hostile, and we had to get in. So that's the lobbyist safe-cracker method: throw fundraisers, raise money, and become a big donor. —Lobbyist Jack Abramoff in 2011 http://en.wikipedia.org/wiki/Lobbying_in_the_United_States
https://wn.com/How_Lobbyists_Secretly_Run_Washington_The_Rich,_Money_Influencing_Congress,_Government_(1993)
At Eli Lilly Headquarters: Marketing Big Pharma Profits at Risk to the Public

At Eli Lilly Headquarters: Marketing Big Pharma Profits at Risk to the Public

  • Order:
  • Duration: 7:23
  • Updated: 14 Aug 2015
  • views: 5536
videos
We visit the headquarters of Eli Lilly in downtown Indianapolis where the power of Big Pharma has carved out Indiana's political landscape, supplied its lobbyists and operatives, and created an empire of profits by (reportedly) treating the symptoms, hiding the risk and harm, and insisting on the safety of products – like Thimerosal and Prozac – without sufficient testing, and even less regard for the lives affected. Read more at Truthstream: http://truthstreammedia.com/2015/08/14/visiting-eli-lilly-headquarters-marketing-big-pharma-profits-at-the-expense-of-public-safety/ With the shameful record of having only one sham of a study on the safety of Thimerosal back in the 1920s, Eli Lilly has had the gall to insist upon the safety of their products, even as lobbyists in Washington moved to get a secret rider in the Patriot Act to give immunity to legislation to companies in cases of autism linked to thimerosal-containing vaccines. http://www.counterpunch.org/2010/01/22/the-mystery-of-the-eli-lilly-rider/ Meanwhile, Congressional inquiries are given the run around, whistleblowers have their character assassinated and concerned parents and citizens are ignored, scorned or ridiculed in the mainstream media. There admittedly more than 100,000 deaths each year in America that are caused by prescribed use of pharmaceutical drugs – and big damages awarded in vaccine courts (funded by taxpayers, not vaccine companies). http://www.alternet.org/story/147318/100,000_americans_die_each_year_from_prescription_drugs,_while_pharma_companies_get_rich And yet, the FDA is not doing its job, the problem is not going away, and more and more drugs are rolled out each year. Why does it have to be this way? Truthstream Can Be Found Here: Website: http://TruthstreamMedia.com FB: http://Facebook.com/TruthstreamMedia Twitter: @TruthstreamNews Newsletter: http://eepurl.com/bbxcWX ~*~*~*~*~*~*~*~*~*~*~*~*~*~*~*­~*~*~*~*~ Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use.
https://wn.com/At_Eli_Lilly_Headquarters_Marketing_Big_Pharma_Profits_At_Risk_To_The_Public
How Big Pharma Played a Double Game on Obamacare (w/ Eli Clifton)

How Big Pharma Played a Double Game on Obamacare (w/ Eli Clifton)

  • Order:
  • Duration: 13:37
  • Updated: 17 Apr 2014
  • views: 972
videos
Eli Clifton, reporting fellow with The Investigative Fund at The Nation Institute, joins us to explain how Pharma played a double game on the ACA, how the Obama Administration cut deals with Pharma and Pharma funded ALEC in fighting health reform on the state level and the skill and personality of Billy Tauzin Pharma's former top lobbyist... This clip from the Majority Report, live M-F at 12 noon EST and via daily podcast at http://Majority.FM Subscribe to us on YouTube: http://youtube.com/user/SamSeder
https://wn.com/How_Big_Pharma_Played_A_Double_Game_On_Obamacare_(W_Eli_Clifton)
Grover Norquist Faces Questions About Big Pharma Cash And His Lobbying Past

Grover Norquist Faces Questions About Big Pharma Cash And His Lobbying Past

  • Order:
  • Duration: 6:42
  • Updated: 22 Jun 2012
  • views: 2527
videos https://wn.com/Grover_Norquist_Faces_Questions_About_Big_Pharma_Cash_And_His_Lobbying_Past
Draining the Pharma swamp: Donald Trump announces plan to hammer Big Pharma’s monopoly profits

Draining the Pharma swamp: Donald Trump announces plan to hammer Big Pharma’s monopoly profits

  • Order:
  • Duration: 9:57
  • Updated: 12 Jan 2017
  • views: 6011
videos
President-elect Donald Trump announced a plan to shatter the monopolistic pricing of Big Pharma that has been draining literally trillions of dollars from the government for the past two decades. “Pharma has a lot of lobbyists and a lot of power,” said Trump. “There’s very little bidding on drugs. We’re the largest drug buyer in the world, and we’re going to start bidding. We’re going to start saving billions of dollars on drugs.” Read the full story here: http://www.naturalnews.com/2017-01-11-donald-trump-announces-plan-to-attack-big-pharma-monopoly-profits-by-requiring-competitive-bidding-government-drug-purchases.html
https://wn.com/Draining_The_Pharma_Swamp_Donald_Trump_Announces_Plan_To_Hammer_Big_Pharma’S_Monopoly_Profits
THE SWAMP: Big Pharma Spent $468,108 Per Member Of Congress

THE SWAMP: Big Pharma Spent $468,108 Per Member Of Congress

  • Order:
  • Duration: 9:13
  • Updated: 07 Jul 2017
  • views: 26203
videos
Read More At: http://www.motherjones.com/politics/2016/10/drug-industry-pharmaceutical-lobbyists-medicare-part-d-prices/ Support The Show On Patreon: https://www.patreon.com/seculartalk Here's Our Amazon Link: https://www.amazon.com/?tag=seculacom-20 Follow Kyle on Twitter: http://www.twitter.com/kylekulinski Like the show on Facebook: http://www.facebook.com/SecularTalk Clip from The Kyle Kulinski Show, which airs live on Blog Talk Radio and Secular Talk Radio Monday - Friday 11:00 AM - 12:30 PM Eastern time zone. Listen to the Live Show or On Demand archive at: http://www.blogtalkradio.com/kylekulinski Check out our website - and become a member - at: http://www.SecularTalkRadio.com
https://wn.com/The_Swamp_Big_Pharma_Spent_468,108_Per_Member_Of_Congress
Turn the spotlight on EU lobbying!

Turn the spotlight on EU lobbying!

  • Order:
  • Duration: 1:27
  • Updated: 21 Mar 2016
  • views: 2922
videos
Sign our petition and call for an effective mandatory EU lobby register: www.change.org/eu-lobbying Secretive lobbying undermines democracy and citizens’ trust in governments and the EU institutions. Transparency International’s research shows that hidden and undue influence by lobbyists continues to shape laws across Europe. We have seen pharma lobbying keeping dangerous medicines on the market. We have seen banks writing the laws and regulations that are supposed to control them. And we have seen restrictions for the tobacco and alcohol industries pushed back time and again. Many fear that the Transatlantic Free Trade agreement (TTIP) is shaped by big-business lobbying, but without transparency we don’t know if politicians are making decisions in the best interest of the public. This is because the current rules are weak or just voluntary. There is a risk that those with the most money and the best connections are influencing politics unfairly. Transparency International is working hard to shed more light on EU lobbying. We need much stricter rules. Without a reliable register we cannot even be sure how many lobbyists there are, how much money they spend and which laws they are trying to influence. Jean-Claude Juncker, President of the European Commission, has promised to make his Commission the most transparent ever and to create a mandatory lobby register for the EU Institutions. The petitioners urge the three EU Institutions (Commission, Parliament and Council) to live up to their political promises, by: 1. Making sure that all lobby organisations sign up to the EU Register. Unregistered lobby organisations should no longer get meetings and should not be invited to hearings or expert groups. 2. Ensuring that all EU institutions are covered, including the Council which has not even joined the current voluntary system. Political leaders and their close advisors should publish their meetings online. 3. Making the information provided on the register much more reliable. Therefore we need a robust monitoring system and sanctions for those lobbyists that do not play by the rules. Help us to turn the spotlight on EU lobbying.
https://wn.com/Turn_The_Spotlight_On_Eu_Lobbying
×